MARSEGLIA, GIUSEPPE
MARSEGLIA, GIUSEPPE
Dipartimento di Scienze degli Alimenti e del Farmaco
A sulfonyl fluoride derivative inhibits EGFR L858R/T790M/C797S by covalent modification of the catalytic lysine
2021-01-01 Ferlenghi, F; Scalvini, L; Vacondio, F; Castelli, R; Bozza, N; Marseglia, G; Rivara, S; Lodola, A; La Monica, S; Minari, R; Petronini, Pg; Alfieri, R; Tiseo, M; Mor, M.
Chemical modification of NSC12 leads to a specific FGF-trap with antitumor activity in multiple myeloma
2021-01-01 Castelli, R.; Taranto, S.; Furiassi, L.; Bozza, N.; Marseglia, G.; Ferlenghi, F.; Rivara, S.; Retini, M.; Bedini, A.; Spadoni, G.; Matarazzo, S.; Ronca, R.; Presta, M.; Mor, M.; Giacomini, A.
Expanding the Arsenal of FGFR Inhibitors: A Novel Chloroacetamide Derivative as a New Irreversible Agent With Anti-proliferative Activity Against FGFR1-Amplified Lung Cancer Cell Lines.
2019-01-01 Fumarola, C; Bozza, N; Castelli, R; Ferlenghi, F; Marseglia, Giuseppe; Lodola, A; Bonelli, M; La Monica, S; Cretella, D; Alfieri, R; Minari, R; Galetti, M; Tiseo, M; Ardizzoni, A; Mor, M; Petronini, Pg.
Fibroblast growth factor receptor inhibitors: patent review (2015–2019)
2019-01-01 Marseglia, Giuseppe; Lodola, Alessio; Mor, Marco; Castelli, Riccardo
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
A sulfonyl fluoride derivative inhibits EGFR L858R/T790M/C797S by covalent modification of the catalytic lysine | 1-gen-2021 | Ferlenghi, F; Scalvini, L; Vacondio, F; Castelli, R; Bozza, N; Marseglia, G; Rivara, S; Lodola, A; La Monica, S; Minari, R; Petronini, Pg; Alfieri, R; Tiseo, M; Mor, M. | |
Chemical modification of NSC12 leads to a specific FGF-trap with antitumor activity in multiple myeloma | 1-gen-2021 | Castelli, R.; Taranto, S.; Furiassi, L.; Bozza, N.; Marseglia, G.; Ferlenghi, F.; Rivara, S.; Retini, M.; Bedini, A.; Spadoni, G.; Matarazzo, S.; Ronca, R.; Presta, M.; Mor, M.; Giacomini, A. | |
Expanding the Arsenal of FGFR Inhibitors: A Novel Chloroacetamide Derivative as a New Irreversible Agent With Anti-proliferative Activity Against FGFR1-Amplified Lung Cancer Cell Lines. | 1-gen-2019 | Fumarola, C; Bozza, N; Castelli, R; Ferlenghi, F; Marseglia, Giuseppe; Lodola, A; Bonelli, M; La Monica, S; Cretella, D; Alfieri, R; Minari, R; Galetti, M; Tiseo, M; Ardizzoni, A; Mor, M; Petronini, Pg. | |
Fibroblast growth factor receptor inhibitors: patent review (2015–2019) | 1-gen-2019 | Marseglia, Giuseppe; Lodola, Alessio; Mor, Marco; Castelli, Riccardo |